From: PGM1 suppresses colorectal cancer cell migration and invasion by regulating the PI3K/AKT pathway
Variable | Number | PGM1 expression | P-value | |
---|---|---|---|---|
High | Low | |||
(N = 38) | (N = 38) | |||
Age(year) | ||||
 < 65 | 59 (77.6%) | 31 (81.6%) | 28 (73.7%) | 0.582 |
 ≥ 65 | 17 (22.4%) | 7 (18.4%) | 10 (26.3%) |  |
Gender | ||||
 Female | 32 (42.1%) | 12 (31.6%) | 20 (52.6%) | 0.104 |
 Male | 44 (57.9%) | 26 (68.4%) | 18 (47.4%) |  |
Tumor size (cm) | ||||
 < 5 | 41 (53.9%) | 26 (68.4%) | 15 (39.5%) | 0.021 |
 ≥ 5 | 35 (46.1%) | 12 (31.6%) | 23 (60.5%) |  |
Differentiation | ||||
 Moderate | 19 (25.0%) | 9 (23.7%) | 10 (26.3%) | 0.447 |
 Poor | 34 (44.7%) | 15 (39.5%) | 19 (50.0%) |  |
 Well | 23 (30.3%) | 14 (36.8%) | 9 (23.7%) |  |
Lymphatic node metastasis | ||||
 Negative | 42 (55.3%) | 28 (73.7%) | 14 (36.8%) | 0.003 |
 Positive | 34 (44.7%) | 10 (26.3%) | 24 (63.2%) |  |
TNM stage | ||||
 I + II | 34 (44.7%) | 25 (65.8%) | 9 (23.7%) |  < 0.001 |
 III + IV | 42 (55.3%) | 13 (34.2%) | 29 (76.3%) |  |
Distant metastasis | ||||
 No | 44 (57.9%) | 27 (71.1%) | 17 (44.7%) | 0.037 |
 Yes | 32 (42.1%) | 11 (28.9%) | 21 (55.3%) |  |
1Â years of survival | 0.003 | |||
 Live | 62 (81.6%) | 36 (94.7%) | 26 (68.4%) |  |
 Dead | 14 (18.4%) | 2 (5.3%) | 12 (31.6%) |  |
5 years of survival |  < 0.001 | |||
 Live | 29 (38.2%) | 23 (60.5%) | 6 (15.8%) |  |
 Dead | 47 (61.8%) | 15 (39.5%) | 32 (84.2%) |  |